{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:15:44Z","timestamp":1792822544670,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10143-021-01509-1","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T03:02:33Z","timestamp":1615172553000},"page":"3107-3124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1769-2712","authenticated-orcid":false,"given":"Mendel","family":"Castle-Kirszbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Maingard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Andrew","family":"Danks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Goldschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronil V.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"1509_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.1.JNS193107","volume":"1","author":"YB Abulhasan","year":"2020","unstructured":"Abulhasan YB, Ortiz Jimenez J, Teitelbaum J, Simoneau G, Angle MR (2020) Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia. J Neurosurg 1:1\u201312. https:\/\/doi.org\/10.3171\/2020.1.JNS193107","journal-title":"J Neurosurg"},{"key":"1509_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neurad.2018.04.001","volume":"46","author":"D Adami","year":"2019","unstructured":"Adami D, Berkefeld J, Platz J, Konczalla J, Pfeilschifter W, Weidauer S, Wagner M (2019) Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? J Neuroradiol J Neuroradiol 46:15\u201324. https:\/\/doi.org\/10.1016\/j.neurad.2018.04.001","journal-title":"J Neuroradiol J Neuroradiol"},{"key":"1509_CR3","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1161\/hs0901.094621","volume":"32","author":"V Aiyagari","year":"2001","unstructured":"Aiyagari V, Cross DT, Deibert E, Dacey RG, Diringer MN (2001) Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage. Stroke 32:1994\u20131997. https:\/\/doi.org\/10.1161\/hs0901.094621","journal-title":"Stroke"},{"key":"1509_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/01.RES.0000091074.33584.F0","volume":"93","author":"T Aizawa","year":"2003","unstructured":"Aizawa T, Wei H, Miano JM, Abe J, Berk BC, Yan C (2003) Role of phosphodiesterase 3 in NO\/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ Res 93:406\u2013413. https:\/\/doi.org\/10.1161\/01.RES.0000091074.33584.F0","journal-title":"Circ Res"},{"key":"1509_CR5","doi-asserted-by":"publisher","unstructured":"Alamri AS, A A, D T, M A, B L, M L, M B, J T (2016) Use of intra-arterial milrinone rescue therapy in patients with refractory and super refractory vasospasm after aneurysmal subarachnoid hemorrhage. J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2016.87","DOI":"10.1017\/cjn.2016.87"},{"key":"1509_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3171\/JNS\/2008\/109\/11\/0918","volume":"109","author":"N Andersson","year":"2008","unstructured":"Andersson N, Malm J, Eklund A (2008) Dependency of cerebrospinal fluid outflow resistance on intracranial pressure: clinical article. J Neurosurg 109:918\u2013922. https:\/\/doi.org\/10.3171\/JNS\/2008\/109\/11\/0918","journal-title":"J Neurosurg"},{"key":"1509_CR7","doi-asserted-by":"publisher","unstructured":"Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S (2001) Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery 48:723-8-discussion 728-30. https:\/\/doi.org\/10.1097\/00006123-200104000-00004","DOI":"10.1097\/00006123-200104000-00004"},{"key":"1509_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.str.18.2.365","volume":"18","author":"IA Awad","year":"1987","unstructured":"Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC (1987) Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 18:365\u2013372. https:\/\/doi.org\/10.1161\/01.str.18.2.365","journal-title":"Stroke"},{"key":"1509_CR9","unstructured":"Barrett KE, Barman SM, Boitano S, Brooks H (2015) Ganong\u2019s Review of Medical Physiology, 25th edn. McGraw Hill Professional"},{"key":"1509_CR10","first-page":"247","volume":"279","author":"MR Bergman","year":"1996","unstructured":"Bergman MR, Holycross BJ (1996) Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors. J Pharmacol Exp Ther 279:247\u2013254","journal-title":"J Pharmacol Exp Ther"},{"key":"1509_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/shk.0000000000000388","volume":"44","author":"MO Bianchi","year":"2015","unstructured":"Bianchi MO, Cheung P-Y, Phillipos E, Aranha-Netto A, Joynt C (2015) The effect of milrinone on splanchnic and cerebral perfusion in infants with congenital heart disease prior to surgery. Shock (Augusta, Ga) 44:115\u2013120. https:\/\/doi.org\/10.1097\/shk.0000000000000388","journal-title":"Shock (Augusta, Ga)"},{"key":"1509_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/STROKEAHA.118.023664","volume":"50","author":"M Bieber","year":"2019","unstructured":"Bieber M, Schuhmann MK, Volz J, Kumar GJ, Vaidya JR, Nieswandt B, Pham M, Stoll G, Kleinschnitz C, Kraft P (2019) Description of a novel phosphodiesterase (PDE)-3 inhibitor protecting mice from ischemic stroke independent from platelet function. Stroke 50:478\u2013486. https:\/\/doi.org\/10.1161\/STROKEAHA.118.023664","journal-title":"Stroke"},{"key":"1509_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejphar.2004.02.038","volume":"489","author":"S Birk","year":"2004","unstructured":"Birk S, Edvinsson L, Olesen J, Kruuse C (2004) Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. Eur J Pharmacol 489:93\u2013100. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.038","journal-title":"Eur J Pharmacol"},{"key":"1509_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrneurol.2013.11","volume":"9","author":"KP Budohoski","year":"2013","unstructured":"Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD (2013) Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol 9:152\u2013163. https:\/\/doi.org\/10.1038\/nrneurol.2013.11","journal-title":"Nat Rev Neurol"},{"key":"1509_CR15","doi-asserted-by":"publisher","unstructured":"Castle-Kirszbaum M, Ayton S, Goldschlager T (2020) Letter to the Editor. Hyperglycolysis as a common cause for elevated lactate in subarachnoid hemorrhage. J Neurosurg 1\u20132. https:\/\/doi.org\/10.3171\/2020.1.JNS20191","DOI":"10.3171\/2020.1.JNS20191"},{"key":"1509_CR16","doi-asserted-by":"crossref","unstructured":"Castle-Kirszbaum M, Parkin WG, Goldschlager T, Lewis PM (2021) Cardiac output and cerebral blood flow: a systematic review of cardio-cerebral coupling. J Neurosurg Anesthesiol. In Press 1\u201333","DOI":"10.1097\/ANA.0000000000000768"},{"key":"1509_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.300.3.787","volume":"300","author":"JM Choi","year":"2002","unstructured":"Choi JM, Shin HK, Kim KY, Lee JH, Hong KW (2002) Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 300:787\u2013793. https:\/\/doi.org\/10.1124\/jpet.300.3.787","journal-title":"J Pharmacol Exp Ther"},{"key":"1509_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00004647-200204000-00011","volume":"22","author":"JF Clark","year":"2002","unstructured":"Clark JF, Reilly M, Sharp FR (2002) Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab 22:472\u2013478. https:\/\/doi.org\/10.1097\/00004647-200204000-00011","journal-title":"J Cereb Blood Flow Metab"},{"key":"1509_CR19","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"CE Sander","year":"2012","unstructured":"Sander CE, Rabinstein AA, Ricardo CJ, Derdeyn CP, Jacques D, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Gregory TB, Paul V (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke 43:1711\u20131737. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839","journal-title":"Stroke"},{"key":"1509_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/jcbfm.2013.208","volume":"34","author":"CHP Cremers","year":"2014","unstructured":"Cremers CHP, van der Schaaf IC, Wensink E, Greving JP, Rinkel GJE, Velthuis BK, Vergouwen MDI (2014) CT perfusion and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 34:200\u2013207","journal-title":"J Cereb Blood Flow Metab"},{"key":"1509_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/ana.0000000000000527","volume":"31","author":"T Crespy","year":"2019","unstructured":"Crespy T, Heintzelmann M, Chiron C, Vinclair M, Tahon F, Francony G, Payen J-F (2019) Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid hemorrhage? J Neurosurg Anesthesiol 31:323\u2013329. https:\/\/doi.org\/10.1097\/ana.0000000000000527","journal-title":"J Neurosurg Anesthesiol"},{"key":"1509_CR22","doi-asserted-by":"publisher","unstructured":"De Leon A, Polderman K, Abrego G c, Alfaro F (2014) Milrinone to improve outcome in cerebral vasospasm after SAH. From april 2012 to april 2013 neuro-ICU caja del seguro social. Panama. Neurocritical Care. https:\/\/doi.org\/10.1007\/s12028-014-0034-4","DOI":"10.1007\/s12028-014-0034-4"},{"key":"1509_CR23","doi-asserted-by":"crossref","unstructured":"Dhar R, Diringer MN (2014) Relationship between angiographic vasospasm, cerebral blood flow, and cerebral infarction after subarachnoid hemorrhage. Springer International Publishing, pp 161\u2013165","DOI":"10.1007\/978-3-319-04981-6_27"},{"key":"1509_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12028-016-0243-0","volume":"25","author":"R Dhar","year":"2016","unstructured":"Dhar R, Washington C, Diringer M, Zazulia A, Jafri H, Derdeyn C, Zipfel G (2016) Acute effect of intravenous sildenafil on cerebral blood flow in patients with vasospasm after subarachnoid hemorrhage. Neurocrit Care 25:201\u2013204. https:\/\/doi.org\/10.1007\/s12028-016-0243-0","journal-title":"Neurocrit Care"},{"key":"1509_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm.2333","volume":"17","author":"JP Dreier","year":"2011","unstructured":"Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17:439\u2013447. https:\/\/doi.org\/10.1038\/nm.2333","journal-title":"Nat Med"},{"key":"1509_CR26","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/brain\/awp102","volume":"132","author":"JP Dreier","year":"2009","unstructured":"Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, Tolias C, Oliveira-Ferreira AI, Fabricius M, Hartings JA, Vajkoczy P, Lauritzen M, Dirnagl U, Bohner G, Strong AJ, group C study (2009) Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132:1866\u20131881. https:\/\/doi.org\/10.1093\/brain\/awp102","journal-title":"Brain"},{"key":"1509_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00005344-198705000-00010","volume":"9","author":"H Drexler","year":"1987","unstructured":"Drexler H, H\u00f6ing S, Faude F, Wollschl\u00e4ger H, Just H (1987) Central and regional vascular hemodynamics following intravenous milrinone in the conscious rat: comparison with dobutamine. J Cardiovasc Pharmacol 9:563\u2013569. https:\/\/doi.org\/10.1097\/00005344-198705000-00010","journal-title":"J Cardiovasc Pharmacol"},{"key":"1509_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1212\/01.wnl.0000319690.82357.44","volume":"71","author":"SV Eden","year":"2008","unstructured":"Eden SV, Meurer WJ, S\u00e1nchez BN, Lisabeth LD, Smith MA, Brown DL, Morgenstern LB (2008) Gender and ethnic differences in subarachnoid hemorrhage. Neurology 71:731\u2013735. https:\/\/doi.org\/10.1212\/01.wnl.0000319690.82357.44","journal-title":"Neurology"},{"key":"1509_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","volume":"39","author":"AT Fraticelli","year":"2008","unstructured":"Fraticelli AT, Cholley BP, Losser M-R, Saint Maurice J-P, Payen D (2008) Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 39:893\u2013898. https:\/\/doi.org\/10.1161\/STROKEAHA.107.492447","journal-title":"Stroke"},{"key":"1509_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1227\/01.neu.0000359530.04529.07","volume":"66","author":"JA Frontera","year":"2010","unstructured":"Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, Connolly ES, Mayer SA (2010) Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage. Neurosurgery 66:35\u201341. https:\/\/doi.org\/10.1227\/01.neu.0000359530.04529.07","journal-title":"Neurosurgery"},{"key":"1509_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/strokeaha.117.017956","volume":"49","author":"CS Gathier","year":"2018","unstructured":"Gathier CS, van den Bergh WM, van der Jagt M, Verweij BH, Dankbaar JW, M\u00fcller MC, Oldenbeuving AW, Rinkel GJE, Slooter AJC, Group H-S (2018) Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 49:76\u201383. https:\/\/doi.org\/10.1161\/strokeaha.117.017956","journal-title":"Stroke"},{"key":"1509_CR32","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1161\/strokeaha.115.010537","volume":"46","author":"CS Gathier","year":"2015","unstructured":"Gathier CS, Dankbaar JW, van der Jagt M, Verweij BH, Oldenbeuving AW, Rinkel GJE, van den Bergh WM, Slooter AJC, Group H-S (2015) Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 46:3277\u20133281. https:\/\/doi.org\/10.1161\/strokeaha.115.010537","journal-title":"Stroke"},{"key":"1509_CR33","doi-asserted-by":"publisher","unstructured":"Ghanem MA, Shabana AM (2014) Effects of milrinone continuous intravenous infusion on global cerebral oxygenation and cerebral vasospasm after cerebral aneurysm surgical clipping. J Anaesth. https:\/\/doi.org\/10.1016\/j.egja.2013.07.006","DOI":"10.1016\/j.egja.2013.07.006"},{"key":"1509_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41467-020-14330-z","volume":"11","author":"S Grubb","year":"2020","unstructured":"Grubb S, Cai C, Hald BO, Khennouf L, Murmu RP, Jensen AGK, Fordsmann J, Zambach S, Lauritzen M (2020) Precapillary sphincters maintain perfusion in the cerebral cortex. Nat Commun 11:395. https:\/\/doi.org\/10.1038\/s41467-020-14330-z","journal-title":"Nat Commun"},{"key":"1509_CR35","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/strokeaha.118.022310","volume":"49","author":"NM Haegens","year":"2018","unstructured":"Haegens NM, Gathier CS, Horn J, Coert BA, Verbaan D, van den Bergh WM (2018) Induced hypertension in preventing cerebral infarction in delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 49:2630\u20132636. https:\/\/doi.org\/10.1161\/strokeaha.118.022310","journal-title":"Stroke"},{"key":"1509_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/jcbfm.1981.36","volume":"1","author":"SI Harik","year":"1981","unstructured":"Harik SI, Sharma VK, Wetherbee JR, Warren RH, Banerjee SP (1981) Adrenergic and cholinergic receptors of cerebral microvessels. J Cereb Blood Flow Metab 1:329\u2013338. https:\/\/doi.org\/10.1038\/jcbfm.1981.36","journal-title":"J Cereb Blood Flow Metab"},{"key":"1509_CR37","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0003-4975(99)00716-X","volume":"68","author":"N Hayashida","year":"1999","unstructured":"Hayashida N, Tomoeda H, Oda T, Tayama E, Chihara S, Kawara T, Aoyagi S (1999) Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. Ann Thorac Surg 68:1661\u20131667. https:\/\/doi.org\/10.1016\/S0003-4975(99)00716-X","journal-title":"Ann Thorac Surg"},{"key":"1509_CR38","unstructured":"Higgins JPT, Cochrane Collaboration (2020) Cochrane handbook for systematic reviews of interventions, Second edn. Wiley-Blackwell, Hoboken, NJ"},{"key":"1509_CR39","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/0002-8703(91)90828-6","volume":"121","author":"P Honerj\u00e4ger","year":"1991","unstructured":"Honerj\u00e4ger P (1991) Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 121:1939\u20131944. https:\/\/doi.org\/10.1016\/0002-8703(91)90828-6","journal-title":"Am Heart J"},{"key":"1509_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00000539-200107000-00035","volume":"93","author":"H Iida","year":"2001","unstructured":"Iida H, Iida M, Takenaka M, Oda A, Uchida M, Fujiwara H, Dohi S (2001) The effects of alpha-human atrial natriuretic peptide and milrinone on pial vessels during blood-brain barrier disruption in rabbits. Anesth Analg 93:177\u2013182. https:\/\/doi.org\/10.1097\/00000539-200107000-00035","journal-title":"Anesth Analg"},{"key":"1509_CR41","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1212\/wnl.0000000000007862","volume":"93","author":"R Jabbarli","year":"2019","unstructured":"Jabbarli R, Pierscianek D, R\u00f6lz R, Oppong MD, Kaier K, Shah M, Taschner C, M\u00f6nninghoff C, Urbach H, Beck J, Sure U, Forsting M (2019) Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: more is more. Neurology 93:e458\u2013e466. https:\/\/doi.org\/10.1212\/wnl.0000000000007862","journal-title":"Neurology"},{"key":"1509_CR42","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1161\/STROKEAHA.112.659888","volume":"43","author":"M Jaeger","year":"2012","unstructured":"Jaeger M, Soehle M, Schuhmann MU, Meixensberger J (2012) Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke 43:2097\u20132101","journal-title":"Stroke"},{"key":"1509_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3171\/jns.1999.90.3.0463","volume":"90","author":"JS Jeng","year":"1999","unstructured":"Jeng JS, Yip PK, Huang SJ, Kao MC (1999) Changes in hemodynamics of the carotid and middle cerebral arteries before and after endoscopic sympathectomy in patients with palmar hyperhidrosis: preliminary results. J Neurosurg 90:463\u2013467. https:\/\/doi.org\/10.3171\/jns.1999.90.3.0463","journal-title":"J Neurosurg"},{"key":"1509_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/jcbfm.2011.153","volume":"32","author":"SN Jespersen","year":"2012","unstructured":"Jespersen SN, \u00d8stergaard L (2012) The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow Metab 32:264\u2013277. https:\/\/doi.org\/10.1038\/jcbfm.2011.153","journal-title":"J Cereb Blood Flow Metab"},{"key":"1509_CR45","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/01.cir.91.5.1314","volume":"91","author":"R Joannides","year":"1995","unstructured":"Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314\u20131319. https:\/\/doi.org\/10.1161\/01.cir.91.5.1314","journal-title":"Circulation"},{"key":"1509_CR46","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3171\/jns.1996.85.5.0908","volume":"85","author":"Y Kajita","year":"1996","unstructured":"Kajita Y, Dietrich HH, Dacey RGJ (1996) Effects of oxyhemoglobin on local and propagated vasodilatory responses induced by adenosine, adenosine diphosphate, and adenosine triphosphate in rat cerebral arterioles. J Neurosurg 85:908\u2013916. https:\/\/doi.org\/10.3171\/jns.1996.85.5.0908","journal-title":"J Neurosurg"},{"key":"1509_CR47","first-page":"864","volume":"242","author":"RF Kauffman","year":"1987","unstructured":"Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML (1987) In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 242:864\u2013872","journal-title":"J Pharmacol Exp Ther"},{"key":"1509_CR48","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/brain\/awy143","volume":"141","author":"L Khennouf","year":"2018","unstructured":"Khennouf L, Gesslein B, Brazhe A, Octeau JC, Kutuzov N, Khakh BS, Lauritzen M (2018) Active role of capillary pericytes during stimulation-induced activity and spreading depolarization. Brain 141:2032\u20132046. https:\/\/doi.org\/10.1093\/brain\/awy143","journal-title":"Brain"},{"key":"1509_CR49","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1227\/01.neu.0000088567.59324.78","volume":"53","author":"DH Kim","year":"2003","unstructured":"Kim DH, Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M (2003) Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Clin Neurosurg 53:1044\u20131052. https:\/\/doi.org\/10.1227\/01.neu.0000088567.59324.78","journal-title":"Clin Neurosurg"},{"key":"1509_CR50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1476-5381.1991.tb12457.x","volume":"104","author":"N Komas","year":"1991","unstructured":"Komas N, Lugnier C, Stoclet JC (1991) Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104:495\u2013503. https:\/\/doi.org\/10.1111\/j.1476-5381.1991.tb12457.x","journal-title":"Br J Pharmacol"},{"key":"1509_CR51","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12028-012-9701-5","volume":"16","author":"M Lannes","year":"2012","unstructured":"Lannes M, Teitelbaum J, Cort\u00e9s M d P, Cardoso M, Angle M (2012) Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital Protocol. Neurocrit Care 16:354\u2013362. https:\/\/doi.org\/10.1007\/s12028-012-9701-5","journal-title":"Neurocrit Care"},{"key":"1509_CR52","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1161\/STROKEAHA.110.595090","volume":"41","author":"DT Laskowitz","year":"2010","unstructured":"Laskowitz DT, Kolls BJ (2010) Neuroprotection in Subarachnoid Hemorrhage. Stroke 41:S79\u2013S84. https:\/\/doi.org\/10.1161\/STROKEAHA.110.595090","journal-title":"Stroke"},{"key":"1509_CR53","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3171\/jns.1993.79.4.0494","volume":"79","author":"ML Levy","year":"1993","unstructured":"Levy ML, Rabb CH, Zelman V, Giannotta SL (1993) Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 79:494\u2013499. https:\/\/doi.org\/10.3171\/jns.1993.79.4.0494","journal-title":"J Neurosurg"},{"key":"1509_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ncpneuro0490","volume":"3","author":"RL Macdonald","year":"2007","unstructured":"Macdonald RL, Pluta RM, Zhang JH (2007) Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Rev Neurol 3:256\u2013263. https:\/\/doi.org\/10.1038\/ncpneuro0490","journal-title":"Nat Rev Neurol"},{"key":"1509_CR55","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.3171\/foc.1997.3.4.6","volume":"3","author":"RL Macdonald","year":"1997","unstructured":"Macdonald RL, Weir B, Zhang J, Marton LS, Sajdak M, Johns LM (1997) Adenosine triphosphate and hemoglobin in vasospastic monkeys. Neurosurg Focus 3:e3","journal-title":"Neurosurg Focus"},{"key":"1509_CR56","doi-asserted-by":"publisher","unstructured":"Miller JA, Jr RGD, Diringer MN (1995) Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 26:2260\u20132266. https:\/\/doi.org\/10.1161\/01.str.26.12.2260","DOI":"10.1161\/01.str.26.12.2260"},{"key":"1509_CR57","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339. https:\/\/doi.org\/10.1136\/bmj.b2535","DOI":"10.1136\/bmj.b2535"},{"key":"1509_CR58","doi-asserted-by":"publisher","first-page":"C77","DOI":"10.1007\/BF01972726","volume":"39","author":"K Molnar-Kimber","year":"1993","unstructured":"Molnar-Kimber K, Yonno L, Heaslip R, Weichman B (1993) Modulation of TNF\u03b1 and IL-1\u03b2 from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 39:C77\u2013C79. https:\/\/doi.org\/10.1007\/BF01972726","journal-title":"Agents Actions"},{"key":"1509_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-017-0379-6","volume":"27","author":"A Murphy","year":"2017","unstructured":"Murphy A, Manoel AL d O, Macdonald RL, Baker A, Lee T-Y, Marotta T, Montanera W, Aviv R, Bharatha A (2017) Changes in cerebral perfusion with induced hypertension in aneurysmal subarachnoid hemorrhage: a pilot and feasibility study. Neurocrit Care 27:3\u201310. https:\/\/doi.org\/10.1007\/s12028-017-0379-6","journal-title":"Neurocrit Care"},{"key":"1509_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0163-7258(90)90060-F","volume":"47","author":"KJ Murray","year":"1990","unstructured":"Murray KJ (1990) Cyclic AMP and mechanisms of vasolidation. Pharmacol Ther 47:329\u2013345. https:\/\/doi.org\/10.1016\/0163-7258(90)90060-F","journal-title":"Pharmacol Ther"},{"key":"1509_CR61","doi-asserted-by":"crossref","unstructured":"Mutoh T, Ishikawa T, Kazumata K, Matsumoto K, Taki Y, Suzuki A (2014) Dobutamine versus mirlinone for intensive hemodynamic augmentation to relieve clinical delayed cerebral ischemia after subarachnoid hemorrhage. Stroke","DOI":"10.1161\/str.45.suppl_1.tp355"},{"key":"1509_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/1440-1681.12718","volume":"44","author":"T Mutoh","year":"2017","unstructured":"Mutoh T, Mutoh T, Nakamura K, Yamamoto Y, Tsuru Y, Tsubone H, Ishikawa T, Taki Y (2017) Acute cardiac support with intravenous milrinone promotes recovery from early brain injury in a murine model of severe subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 44:463\u2013469. https:\/\/doi.org\/10.1111\/1440-1681.12718","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1509_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2017.01.008","volume":"640","author":"T Mutoh","year":"2017","unstructured":"Mutoh T, Mutoh T, Sasaki K, Nakamura K, Tatewaki Y, Ishikawa T, Taki Y (2017) Neurocardiac protection with milrinone for restoring acute cerebral hypoperfusion and delayed ischemic injury after experimental subarachnoid hemorrhage. Neurosci Lett 640:70\u201375. https:\/\/doi.org\/10.1016\/j.neulet.2017.01.008","journal-title":"Neurosci Lett"},{"key":"1509_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0006-8993(86)90703-1","volume":"381","author":"K Nakai","year":"1986","unstructured":"Nakai K, Itakura T, Naka Y, Nakakita K, Kamei I, Imai H, Yokote H, Komai N (1986) The distribution of adrenergic receptors in cerebral blood vessels: an autoradiographic study. Brain Res 381:148\u2013152. https:\/\/doi.org\/10.1016\/0006-8993(86)90703-1","journal-title":"Brain Res"},{"key":"1509_CR65","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1227\/01.neu.0000363153.62579.ff","volume":"66","author":"M Nishiguchi","year":"2010","unstructured":"Nishiguchi M, Ono S, Iseda K, Manabe H, Hishikawa T, Date I (2010) Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone. Neurosurgery 66:158\u2013164. https:\/\/doi.org\/10.1227\/01.neu.0000363153.62579.ff","journal-title":"Neurosurgery"},{"key":"1509_CR66","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/foc.2006.21.3.1","volume":"21","author":"CP Nolan","year":"2006","unstructured":"Nolan CP, Macdonald RL (2006) Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus 21:E1\u2013E8. https:\/\/doi.org\/10.3171\/foc.2006.21.3.1","journal-title":"Neurosurg Focus"},{"key":"1509_CR67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1991.74.1.0014","volume":"74","author":"J Ohman","year":"1991","unstructured":"Ohman J, Servo A, Heiskanen O (1991) Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 74:14\u201320. https:\/\/doi.org\/10.3171\/jns.1991.74.1.0014","journal-title":"J Neurosurg"},{"key":"1509_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13054-016-1193-9","volume":"20","author":"AL de Oliveira Manoel","year":"2016","unstructured":"de Oliveira Manoel AL, Goffi A, Marotta TR, Schweizer TA, Abrahamson S, Macdonald RL (2016) The critical care management of poor-grade subarachnoid haemorrhage. Crit Care 20:21. https:\/\/doi.org\/10.1186\/s13054-016-1193-9","journal-title":"Crit Care"},{"key":"1509_CR69","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1111\/bph.12647","volume":"171","author":"O Orstavik","year":"2014","unstructured":"Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J-B, Qvigstad E (2014) Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart. Br J Pharmacol 171:5169\u20135181. https:\/\/doi.org\/10.1111\/bph.12647","journal-title":"Br J Pharmacol"},{"key":"1509_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/bf01420187","volume":"103","author":"H Otsubo","year":"1990","unstructured":"Otsubo H, Takemae T, Inoue T, Kobayashi S, Sugita K (1990) Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage. Acta Neurochir 103:18\u201326. https:\/\/doi.org\/10.1007\/bf01420187","journal-title":"Acta Neurochir"},{"key":"1509_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-4682-3-31","volume":"3","author":"PR Painter","year":"2006","unstructured":"Painter PR, Ed\u00e9n P, Bengtsson H-U (2006) Pulsatile blood flow, shear force, energy dissipation and Murray\u2019s Law. Theor Biol Med Model 3:31\u201310. https:\/\/doi.org\/10.1186\/1742-4682-3-31","journal-title":"Theor Biol Med Model"},{"key":"1509_CR72","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3171\/2014.10.JNS14290","volume":"122","author":"M Pegoli","year":"2015","unstructured":"Pegoli M, Mandrekar J, Rabinstein AA, Lanzino G (2015) Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 122:414\u2013418. https:\/\/doi.org\/10.3171\/2014.10.JNS14290","journal-title":"J Neurosurg"},{"key":"1509_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2004.10.002","volume":"105","author":"RM Pluta","year":"2005","unstructured":"Pluta RM (2005) Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23\u201356. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.10.002","journal-title":"Pharmacol Ther"},{"key":"1509_CR74","doi-asserted-by":"publisher","first-page":"C1346","DOI":"10.1152\/ajpcell.1998.274.5.C1346","volume":"274","author":"VA Porter","year":"1998","unstructured":"Porter VA, Bonev AD, Knot HJ, Heppner TJ, Stevenson AS, Kleppisch T, Lederer WJ, Nelson MT (1998) Frequency modulation of Ca 2+ sparks is involved in regulation of arterial diameter by cyclic nucleotides. Am J Phys Cell Phys 274:C1346\u2013C1355. https:\/\/doi.org\/10.1152\/ajpcell.1998.274.5.C1346","journal-title":"Am J Phys Cell Phys"},{"key":"1509_CR75","first-page":"33","volume":"10","author":"AI Qureshi","year":"2018","unstructured":"Qureshi AI, Ishfaq A, Ishfaq MF, Pandhi A, Ahmed SI, Singh S, Kerro A, Krishnan R, Deep A, Georgiadis AL (2018) Therapeutic benefit of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized and nonrandomized studies. J Vasc 10:33\u201340","journal-title":"J Vasc"},{"key":"1509_CR76","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00003246-200003000-00035","volume":"28","author":"AI Qureshi","year":"2000","unstructured":"Qureshi AI, Suarez JI, Bhardwaj A, Yahia AM, Tamargo RJ, Ulatowski JA (2000) Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 28:824\u2013829. https:\/\/doi.org\/10.1097\/00003246-200003000-00035","journal-title":"Crit Care Med"},{"key":"1509_CR77","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3171\/jns.2005.103.6.0974","volume":"103","author":"A Raabe","year":"2005","unstructured":"Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V (2005) Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 103:974\u2013981. https:\/\/doi.org\/10.3171\/jns.2005.103.6.0974","journal-title":"J Neurosurg"},{"key":"1509_CR78","doi-asserted-by":"publisher","unstructured":"Rouanet C, Reges D, Rocha E, Gagliardi V, Silva G (2017) Treatment with milrinone of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: a tertiary academic hospital experience. Eur Stroke J. https:\/\/doi.org\/10.1177\/2396987317705242","DOI":"10.1177\/2396987317705242"},{"key":"1509_CR79","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000458536","volume":"43","author":"B Roy","year":"2017","unstructured":"Roy B, McCullough LD, Dhar R, Grady J, Wang Y-B, Brown RJ (2017) Comparison of initial vasopressors used for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 43:266\u2013271. https:\/\/doi.org\/10.1159\/000458536","journal-title":"Cerebrovasc Dis"},{"key":"1509_CR80","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s12272-010-0711-6","volume":"33","author":"R Saklani","year":"2010","unstructured":"Saklani R, Jaggi A, Singh N (2010) Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. Arch Pharm Res 33:1049\u20131057. https:\/\/doi.org\/10.1007\/s12272-010-0711-6","journal-title":"Arch Pharm Res"},{"key":"1509_CR81","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.3174\/ajnr.A3782","volume":"35","author":"PC Sanelli","year":"2014","unstructured":"Sanelli PC, Kishore S, Gupta A, Mangat H, Rosengart A, Kamel H, Segal A (2014) Delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: proposal of an evidence-based combined clinical and imaging reference standard. AJNR Am J Neuroradiol 35:2209\u20132214. https:\/\/doi.org\/10.3174\/ajnr.A3782","journal-title":"AJNR Am J Neuroradiol"},{"key":"1509_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00008506-200004000-00002","volume":"12","author":"K Sato","year":"2000","unstructured":"Sato K, Yoshimoto A (2000) Effects of olprinone on systemic and cerebral circulation in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol 12:81\u201383","journal-title":"J Neurosurg Anesthesiol"},{"key":"1509_CR83","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3171\/JNS.2008.109.12.1052","volume":"109","author":"JM Schmidt","year":"2008","unstructured":"Schmidt JM, Wartenberg KE, Fernandez A, Claassen J, Rincon F, Ostapkovich ND, Badjatia N, Parra A, Connolly ES, Mayer SA (2008) Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg 109:1052\u20131059. https:\/\/doi.org\/10.3171\/JNS.2008.109.12.1052","journal-title":"J Neurosurg"},{"key":"1509_CR84","doi-asserted-by":"publisher","unstructured":"Shan T, Zhang T, Qian W, Ma L, Li H, You C, Xie X (2019) Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09198-z","DOI":"10.1007\/s00415-019-09198-z"},{"key":"1509_CR85","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/archsurg.1969.01340090093015","volume":"98","author":"HA Shenkin","year":"1969","unstructured":"Shenkin HA (1969) Cervical sympathectomy on patients with occlusive cerebrovascular disease. Arch Surg 98:317\u2013320. https:\/\/doi.org\/10.1001\/archsurg.1969.01340090093015","journal-title":"Arch Surg"},{"key":"1509_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1172\/JCI102421","volume":"30","author":"HA Shenkin","year":"1951","unstructured":"Shenkin HA, Cabieses F, Van Den Noordt G (1951) The effect of bilateral stellectomy upon the cerebral circulation of man. J Clin Invest 30:90\u201393. https:\/\/doi.org\/10.1172\/JCI102421","journal-title":"J Clin Invest"},{"key":"1509_CR87","doi-asserted-by":"publisher","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. 5. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"1509_CR88","doi-asserted-by":"publisher","unstructured":"Soliman R, Zohry G (2019) Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study. J Anesth. https:\/\/doi.org\/10.1016\/j.bjan.2018.09.005","DOI":"10.1016\/j.bjan.2018.09.005"},{"key":"1509_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc.2006.21.3.2","volume":"21","author":"SC Stein","year":"2006","unstructured":"Stein SC, Levine JM, Nagpal S, LeRoux PD (2006) Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus 21:1\u20137. https:\/\/doi.org\/10.3171\/foc.2006.21.3.2","journal-title":"Neurosurg Focus"},{"key":"1509_CR90","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/jcan.2002.29680","volume":"16","author":"CA Sulek","year":"2002","unstructured":"Sulek CA, Blas ML, Lobato EB (2002) Milrinone increases middle cerebral artery blood flow velocity after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 16:64\u201369. https:\/\/doi.org\/10.1053\/jcan.2002.29680","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"pt 1","key":"1509_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2176\/nmc.15pt1.41","volume":"15","author":"J Suzuki","year":"1975","unstructured":"Suzuki J, Iwabuchi T, Hori S (1975) Cervical sympathectomy for cerebral vasospasm after aneurysm rupture. Neurol Med Chir (Tokyo) 15(pt 1):41\u201350. https:\/\/doi.org\/10.2176\/nmc.15pt1.41","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1509_CR92","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3171\/jns.1992.77.2.0253","volume":"77","author":"BI Tranmer","year":"1992","unstructured":"Tranmer BI, Keller TS, Kindt GW, Archer D (1992) Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. J Neurosurg 77:253\u2013259. https:\/\/doi.org\/10.3171\/jns.1992.77.2.0253","journal-title":"J Neurosurg"},{"key":"1509_CR93","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/01.STR.17.2.202","volume":"17","author":"T Tsukahara","year":"1986","unstructured":"Tsukahara T, Taniguchi T, Shimohama S, Fujiwara M, Handa H (1986) Characterization of beta adrenergic receptors in human cerebral arteries and alteration of the receptors after subarachnoid hemorrhage. Stroke 17:202\u2013207. https:\/\/doi.org\/10.1161\/01.STR.17.2.202","journal-title":"Stroke"},{"key":"1509_CR94","doi-asserted-by":"publisher","unstructured":"Vas N, Beigh A, Alabdulraheem N, Bosnjakovic P, Abulhasan Y (2013) Targeted intra-arterial milrinone for the treatment of symptomatic cerebral vasospasm in aneurysmal sah. Neurocritical Care. https:\/\/doi.org\/10.1007\/s12028-013-9895-1","DOI":"10.1007\/s12028-013-9895-1"},{"key":"1509_CR95","doi-asserted-by":"publisher","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YBWEM (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391\u20132395. https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275","DOI":"10.1161\/STROKEAHA.110.589275"},{"key":"1509_CR96","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3171\/2015.2.JNS142752","volume":"124","author":"CW Washington","year":"2016","unstructured":"Washington CW, Derdeyn CP, Dhar R, Arias EJ, Chicoine MR, Cross DT, Dacey RGJ, Han BH, Moran CJ, Rich KM, Vellimana AK, Zipfel GJ (2016) A phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 124:318\u2013327. https:\/\/doi.org\/10.3171\/2015.2.JNS142752","journal-title":"J Neurosurg"},{"key":"1509_CR97","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2165\/00003495-198836020-00003","volume":"36","author":"RA Young","year":"1988","unstructured":"Young RA, Ward A (1988) Milrinone: a preliminary review of its pharmacological properties and therapeutic use. Drugs 36:158\u2013192. https:\/\/doi.org\/10.2165\/00003495-198836020-00003","journal-title":"Drugs"},{"key":"1509_CR98","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00005344-200104000-00004","volume":"37","author":"K Yukiiri","year":"2001","unstructured":"Yukiiri K, Mizushige K, Ueda T, Nishiyama Y, Aoyama T, Kohno M (2001) Effects of olprinone, a phosphodiesterase 3 inhibitor, on regional cerebral blood flow of cerebral cortex in stroke patients. J Cardiovasc Pharmacol 37:375\u2013380. https:\/\/doi.org\/10.1097\/00005344-200104000-00004","journal-title":"J Cardiovasc Pharmacol"},{"key":"1509_CR99","unstructured":"Milrinone - Full product Information. In: MIMS Online. https:\/\/www.mimsonline.com.au.acs.hcn.com.au\/Search\/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=milrinone&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=38220001_2. Accessed 6 Jun 2020"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-021-01509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-021-01509-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-021-01509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T16:09:24Z","timestamp":1636992564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-021-01509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1007\/s10143-021-01509-1","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"27 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}